Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhRIG and Rabies Vaccine in Healthy Adults
NCT02559921Phase 2Completed
- Sponsor
- Beijing Chaoyang District Center for Disease Control and Prevention
- Start
- Dec 2014
- Primary completion
- Aug 2015
- Modality
- Monoclonal Antibodies
01
Overview
Phase 2, randomised, double-blind trial of ormutivimab in rabies, sponsored by Beijing Chaoyang District Center for Disease Control and Prevention. Started Dec 2014; status: completed.
02
Drugs
ormutivimab
03
Conditions
rabies
Beyond the preview
Go deeper on NCT02559921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02559921.